{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:22:52Z","timestamp":1760548972418},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T00:00:00Z","timestamp":1275350400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1016\/j.radonc.2010.03.006","type":"journal-article","created":{"date-parts":[[2010,4,11]],"date-time":"2010-04-11T04:24:08Z","timestamp":1270959848000},"page":"308-311","source":"Crossref","is-referenced-by-count":28,"title":["Chemoreirradiation for recurrent salivary gland malignancies"],"prefix":"10.1016","volume":"95","author":[{"given":"Aaron W.","family":"Pederson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel J.","family":"Haraf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth A.","family":"Blair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin M.","family":"Stenson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary-Ellyn","family":"Witt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Everett E.","family":"Vokes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph K.","family":"Salama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2010.03.006_bib1","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/archotol.1990.01870030054008","article-title":"Malignant tumors of major salivary gland origin. A matched-pair analysis of the role of combined surgery and postoperative radiotherapy","volume":"116","author":"Armstrong","year":"1990","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2010.03.006_bib2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0360-3016(93)90233-L","article-title":"Neutron versus photon irradiation for unresectable salivary gland tumors: final report of an RTOG-MRC randomized clinical trial. Radiation Therapy Oncology Group. Medical Research Council","volume":"27","author":"Laramore","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2010.03.006_bib3","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1016\/j.ijrobp.2007.04.079","article-title":"Postoperative and primary radiotherapy for salivary gland carcinomas: indications, techniques, and results","volume":"69","author":"Terhaard","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2010.03.006_bib4","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/1097-0142(197712)40:6<2882::AID-CNCR2820400618>3.0.CO;2-I","article-title":"Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures","volume":"40","author":"Fu","year":"1977","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2010.03.006_bib5","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/jso.2930450112","article-title":"Postoperative radiation therapy for major salivary gland malignancies","volume":"45","author":"Harrison","year":"1990","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib6","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ijrobp.2006.06.050","article-title":"Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas","volume":"66","author":"Chen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2010.03.006_bib7","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1053\/j.seminoncol.2008.03.009","article-title":"Salivary gland malignancies: the role for chemotherapy and molecular targeted agents","volume":"35","author":"Surakanti","year":"2008","journal-title":"Semin Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ijrobp.2005.07.005","article-title":"Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma","volume":"64","author":"Salama","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2010.03.006_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1288\/00005537-199206000-00007","article-title":"Concomitant chemoradiotherapy with cisplatin, 5-fluorouracil and hydroxyurea in poor-prognosis head and neck cancer","volume":"102","author":"Haraf","year":"1992","journal-title":"Laryngoscope"},{"key":"10.1016\/j.radonc.2010.03.006_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00130404-200503000-00009","article-title":"Study of concomitant chemoradiotherapy with irinotecan, 5-FU, and hydroxyurea for patients with advanced and\/or recurrent head and neck cancer","volume":"11","author":"Salama","year":"2005","journal-title":"Cancer J"},{"key":"10.1016\/j.radonc.2010.03.006_bib11","doi-asserted-by":"crossref","first-page":"4922","DOI":"10.1158\/1078-0432.CCR-03-0634","article-title":"Phase I study of concomitant chemoradiotherapy with paclitaxel, fluorouracil, gemcitabine, and twice-daily radiation in patients with poor-prognosis cancer of the head and neck","volume":"10","author":"Milano","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.radonc.2010.03.006_bib12","first-page":"70","article-title":"Paclitaxel, 5-fluorouracil, hydroxyurea, and concomitant radiation therapy for poor-prognosis head and neck cancer","volume":"9","author":"Vokes","year":"1999","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib13","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.radonc.2010.03.006_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/ncponc0750","article-title":"The chemoradiation paradigm in head and neck cancer","volume":"4","author":"Seiwert","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib15","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1200\/JCO.2007.12.2697","article-title":"Chemoradiotherapy for locally advanced head and neck cancer","volume":"25","author":"Salama","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib16","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ijrobp.2004.08.020","article-title":"Reirradiation alternating with docetaxel and cisplatin in inoperable recurrence of head-and-neck cancer: a prospective phase I\/II trial","volume":"61","author":"Hehr","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2010.03.006_bib17","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ijrobp.2003.10.056","article-title":"Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer","volume":"59","author":"Machtay","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2010.03.006_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/jjco\/hyh017","article-title":"Chemo-reirradiation in persistent\/recurrent head and neck cancers","volume":"34","author":"Nagar","year":"2004","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib19","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMra001375","article-title":"Head and neck cancer","volume":"345","author":"Forastiere","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2010.03.006_bib20","unstructured":"Pederson A, Salama J, Haraf D, Witt M, Stenson K, Vokes E, et al. Chemoradiotherapy for locoregionally advanced and high risk salivary gland malignancies. Poster session presented at: 7th International Conference on Head and Neck Cancer; 2008, Jul 19\u201323; San Francisco, CA."},{"key":"10.1016\/j.radonc.2010.03.006_bib21","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/1097-0142(19871215)60:12<2869::AID-CNCR2820601203>3.0.CO;2-Y","article-title":"Cyclophosphamide, doxorubicin, and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin","volume":"60","author":"Dreyfuss","year":"1987","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2010.03.006_bib22","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1200\/JCO.2005.05.3025","article-title":"Systemic therapy in the palliative management of advanced salivary gland cancers","volume":"24","author":"Laurie","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib23","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/oxfordjournals.annonc.a010684","article-title":"Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients","volume":"7","author":"Licitra","year":"1996","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib24","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1200\/JCO.1990.8.6.1056","article-title":"Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma","volume":"8","author":"Dimery","year":"1990","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib25","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archotol.129.9.944","article-title":"Treatment of salivary gland neoplasms with fast neutron radiotherapy","volume":"129","author":"Douglas","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.radonc.2010.03.006_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1634\/theoncologist.8-4-350","article-title":"Intensive concurrent chemoradiotherapy for head and neck cancer with 5-fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure","volume":"8","author":"Argiris","year":"2003","journal-title":"Oncologist"},{"key":"10.1016\/j.radonc.2010.03.006_bib27","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1200\/JCO.2007.11.8612","article-title":"Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and\/or erbB2 expressing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glands","volume":"25","author":"Agulnik","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib28","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S1368-8375(03)00097-6","article-title":"Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study","volume":"39","author":"Haddad","year":"2003","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2010.03.006_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.oraloncology.2004.03.002","article-title":"Herceptin plus chemotherapy in relapsed and\/or metastatic salivary gland cancer","volume":"41","author":"Locati","year":"2005","journal-title":"Oral Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401000157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781401000157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,11]],"date-time":"2018-12-11T21:21:35Z","timestamp":1544563295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781401000157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,6]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["S016781401000157X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2010.03.006","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2010,6]]}}}